CHINA PHARMA HOLDINGS, INC. Receivables, Net, Current
CHINA PHARMA HOLDINGS, INC. (CPHI) had Receivables, Net, Current of $91.75 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2023-08-14
- 2023-06-30: Receivables, Net, Current $91.75K.
- 2022-12-31: Receivables, Net, Current $29.14K.
- 2021-03-31: Receivables, Net, Current $545.09K.
- 2020-12-31: Receivables, Net, Current $501.89K.
| Period end | Receivables, Net, Current |
|---|---|
| 2023-06-30 | $91.75K 10-Q · filed 2023-08-14 |
| 2022-12-31 | $29.14K 10-Q · filed 2023-08-14 |
| 2021-03-31 | $545.09K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $501.89K 10-Q · filed 2021-05-14 |
| 2020-09-30 | $535.06K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $595.73K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $855.08K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $635.37K 10-K · filed 2021-03-26 |
| 2019-09-30 | $693.35K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $680.14K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $845.40K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $916.93K 10-K · filed 2020-03-30 |
| 2018-09-30 | $793.78K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.37M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.47M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $2.29M 10-K · filed 2019-03-28 |
| 2017-09-30 | $2.91M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $3.15M 10-Q · filed 2017-08-14 |
| 2016-12-31 | $4.00M 10-Q · filed 2017-11-14 |
| 2013-03-31 | $62.70M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $66.18M 10-Q · filed 2013-05-14 |
| 2011-12-31 | $69.70M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |